Dr. Jeffrey C. Macaraeg, MD

Dr. Macaraeg practices at CHI Alegent Health Physical Therapy Clinic Bergan - Unit in Omaha, Nebraska.

Dr. Macaraeg's NPI, 1730595158, was assigned on July 7, 2014. Dr. Macaraeg holds Nebraska license 30218.

Dr. Macaraeg's primary practice is CHI Alegent Health Physical Therapy Clinic Bergan - Unit, at 7710 Mercy Rd, Omaha, NE 68124.

Dr. Macaraeg's primary practice is CHI Alegent Health Physical Therapy Clinic Bergan - Unit in Omaha, Nebraska. Dr. Macaraeg is also affiliated with CHI Health Creighton University Medical Center - Bergan Mercy. The medical group on file is CHI Health Clinic. Dmand AI also links Dr. Macaraeg to 4 more hospitals, 2 group practices and clinics, 1 hospital outpatient department and 1 medical group, each named with a free account. Dr. Macaraeg's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Macaraeg practices, 9 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Macaraeg's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Macaraeg's licenses on file in 2 states: Nebraska and Iowa.

CMS data shows 997 Medicare services from Dr. Macaraeg across 11 procedure codes in 2024, for 422 Medicare patients. Medicare paid $61,333 for them.

CMS counts 422 Medicare patients who saw Dr. Macaraeg in 2024. The largest group is 65 to 74, with 165 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Macaraeg's median patient age at 65, with 53% women.

In 2024, Dr. Macaraeg wrote 337 Medicare Part D claims for 60 patients. 27% of them were for generic drugs. CMS names the drug for 275 of them, across 12 drugs with 11 or more claims each, at $274,301 in total drug cost. In 2023, CMS named 208 claims across 11 drugs.

Dr. Macaraeg accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Macaraeg, published from 2020 to 2022. 2020 was the busiest year, with 2. The most frequent topics are Respiratory Insufficiency. Dr. Macaraeg's most frequent co-authors are Karson Fawcett Kalian, DO, Lee E. Morrow, MD and Carrie L. Valenta, MD.

CMS Open Payments shows 205 general payments to Dr. Macaraeg from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,610.